Afinitor (Everolimus): Uses, Side Effects & Warnings

• Afinitor (everolimus) is an mTOR inhibitor used to treat various cancers and certain non-cancerous tumors associated with Tuberous Sclerosis Complex.
• It is prescribed for advanced renal cell carcinoma, specific types of breast cancer, pancreatic neuroendocrine tumors, and subependymal giant cell astrocytoma.
• Common side effects include mouth sores, fatigue, rash, and diarrhea, which often require careful management.
• Serious warnings include increased risk of infections, lung problems (pneumonitis), kidney failure, and impaired wound healing.
• Patients should adhere strictly to dosage instructions and report any unusual symptoms to their healthcare provider immediately.

What is Afinitor (Everolimus) Prescribed For?

Afinitor (everolimus) is a targeted therapy medication primarily used in the treatment of various cancers and certain benign tumors. Its mechanism of action involves inhibiting the mammalian target of rapamycin (mTOR), a protein that regulates cell growth, division, and survival. By blocking mTOR, Afinitor helps to slow down the growth and spread of cancer cells and reduce the size of specific tumors. The broad range of conditions for which it is prescribed highlights its versatility as an antiproliferative agent.

The Afinitor uses and indications span several types of malignancies and non-malignant conditions, making it a significant component of modern therapeutic regimens. Understanding the specific contexts in which this medication is employed is crucial for patients and healthcare providers. This Everolimus drug information emphasizes its role in addressing diseases driven by dysregulated cellular pathways.

Advanced Renal Cell Carcinoma (RCC)

Afinitor is approved for the treatment of advanced renal cell carcinoma (RCC) in patients whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF) targeted therapy. RCC is a type of kidney cancer, and Afinitor offers a crucial option for patients who have not responded to initial treatments, helping to extend progression-free survival.

Subependymal Giant Cell Astrocytoma (SEGA)

For patients with tuberous sclerosis complex (TSC) who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be surgically resected, Afinitor is a vital treatment. SEGA is a non-cancerous brain tumor that can grow and block the flow of cerebrospinal fluid, leading to serious neurological complications. Afinitor helps to shrink these tumors and prevent their growth.

Pancreatic Neuroendocrine Tumors (PNET)

Afinitor is indicated for the treatment of progressive, well-differentiated neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. These tumors, though rare, can be aggressive, and Afinitor provides a targeted approach to manage their growth and spread, improving patient outcomes in this challenging cancer type.

Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

In combination with exemestane, Afinitor is prescribed for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer. This is specifically for patients whose disease has recurred or progressed following treatment with letrozole or anastrozole. Afinitor helps to overcome resistance to endocrine therapy, offering a new avenue for managing this common type of breast cancer.

Tuberous Sclerosis Complex (TSC)-related Angiomyolipoma

Afinitor is also approved for the treatment of adults with tuberous sclerosis complex (TSC) who have renal angiomyolipoma not requiring immediate surgery. Angiomyolipomas are benign tumors that can grow in the kidneys and cause significant complications, including bleeding. Afinitor helps to reduce the size of these tumors, potentially preventing the need for surgical intervention.

Common Side Effects of Everolimus and Management

Like all potent medications, Afinitor (everolimus) can cause a range of side effects, some of which are common and manageable, while others can be more serious. Patients receiving this medication should be aware of potential reactions and communicate any concerns to their healthcare team promptly. Effective management of side effects is crucial for maintaining treatment adherence and improving quality of life.

The Everolimus medication side effects often reflect its mechanism of action, which impacts rapidly dividing cells and immune function. Many patients experience mild to moderate side effects, especially during the initial phases of treatment. A proactive approach to managing these symptoms can significantly alleviate discomfort. This section aims to provide an overview of the common side effects of Everolimus and strategies for their mitigation.

Common side effects often include:

• Stomatitis (Mouth Sores): This is one of the most frequent side effects, characterized by inflammation and sores in the mouth. Management often involves using alcohol-free mouthwashes, pain relievers, and avoiding irritating foods.
• Fatigue: Patients may experience tiredness or lack of energy. Rest, light exercise, and a balanced diet can help manage fatigue.
• Rash: Skin rashes, sometimes acne-like, can occur. Topical creams, moisturizers, and avoiding harsh soaps can provide relief.
• Diarrhea: Loose stools are common. Dietary adjustments, increased fluid intake, and anti-diarrheal medications may be recommended.
• Infections: Due to its immunosuppressive effects, patients may be more susceptible to infections. Vigilance for signs of infection (fever, chills) and prompt medical attention are essential.
• Nausea: Feeling sick to the stomach can be managed with anti-nausea medications and small, frequent meals.
• Loss of Appetite: Patients may experience a reduced desire to eat. Nutritional support and smaller, more appealing meals can help.
• Hyperglycemia (High Blood Sugar): Regular monitoring of blood glucose levels is important, especially for patients with a history of diabetes.
• Hyperlipidemia (High Cholesterol/Triglycerides): Lipid levels should be monitored, and lifestyle changes or medication may be necessary.

It is important for patients to maintain open communication with their healthcare provider about any side effects they experience. Many side effects can be managed effectively with supportive care, dose adjustments, or temporary interruptions in treatment. Never adjust the dosage or stop taking Afinitor without consulting a doctor.

Afinitor Warnings, Precautions, and Contraindications

Afinitor (everolimus) is a powerful medication with significant therapeutic benefits, but it also carries important warnings and precautions that patients and healthcare providers must consider. Understanding these potential risks is paramount to ensuring patient safety and optimizing treatment outcomes. The information provided here serves as a critical part of an Afinitor patient guide, highlighting essential safety considerations.

The Afinitor warnings and precautions are primarily related to its immunosuppressive and antiproliferative effects, which can lead to serious complications. Patients should be thoroughly evaluated before starting treatment and closely monitored throughout therapy. Specific contraindications, though rare, also exist and must be strictly observed to prevent adverse events.

Serious Infections and Immunosuppression

Afinitor can increase the risk of developing serious and potentially fatal infections, including bacterial, fungal, viral, or protozoal infections. This is due to its immunosuppressive properties. Patients should be monitored for signs and symptoms of infection, such as fever, chills, or persistent cough. Prophylactic antibiotics or antiviral agents may be considered in certain high-risk patients. Live vaccines should be avoided during Afinitor treatment.

Lung Problems (Non-infectious Pneumonitis)

Non-infectious pneumonitis, an inflammation of the lungs not caused by infection, is a known and potentially serious side effect of Afinitor. Symptoms may include shortness of breath, cough, and fever. Patients experiencing these symptoms should seek immediate medical attention. Diagnosis often requires imaging studies and exclusion of infectious causes. Depending on the severity, treatment may involve dose reduction, temporary interruption, or discontinuation of Afinitor, along with corticosteroid therapy.

Renal Failure

Cases of renal failure have been reported in patients taking Afinitor. Regular monitoring of kidney function through blood tests (creatinine, BUN) is essential during treatment. Patients with pre-existing kidney impairment may require careful dose adjustments and closer monitoring.

Impaired Wound Healing

Afinitor can impair wound healing, which is a critical consideration for patients undergoing surgery or those with existing wounds. Treatment with Afinitor should be temporarily interrupted before and after planned surgical procedures to minimize this risk. Patients should inform their surgeon about their Afinitor treatment.

Angioedema

Angioedema, a severe allergic reaction characterized by swelling under the skin, has been reported in patients taking Afinitor, particularly when used concurrently with ACE inhibitors. Patients should be advised to seek immediate medical attention if they experience swelling of the face, lips, tongue, or throat, or difficulty breathing.

Liver Impairment

Patients with pre-existing liver impairment may have increased exposure to everolimus, necessitating dose adjustments. Liver function tests should be monitored regularly throughout treatment to detect any signs of liver toxicity.

Taking Everolimus: Dosage and Administration

Proper dosage and administration are critical for the safe and effective use of Afinitor (everolimus). Patients must adhere strictly to their healthcare provider’s instructions and never alter their dosage without medical advice. This section provides general guidelines on how to take Everolimus, emphasizing key considerations for patients to ensure optimal therapeutic outcomes and minimize risks.

Afinitor is typically taken orally, once daily, at the same time each day. It can be taken with or without food, but consistency is key; if taken with food one day, it should be taken with food every day, and vice versa. This consistency helps maintain stable drug levels in the body. The tablets should be swallowed whole and not crushed, chewed, or broken. If a dose is missed, patients should not take a double dose to make up for it; they should take the next scheduled dose as usual.

The specific dosage of Afinitor varies significantly depending on the condition being treated, the patient’s body surface area, and their individual response and tolerance to the medication. For instance, dosages for advanced renal cell carcinoma may differ from those for subependymal giant cell astrocytoma. Regular monitoring of blood levels of everolimus may be performed, especially in certain patient populations, to ensure therapeutic efficacy and minimize toxicity. Patients should also be aware of potential drug interactions, particularly with strong CYP3A4 inhibitors or inducers, which can significantly alter everolimus levels. Always inform your doctor and pharmacist about all medications, supplements, and herbal products you are taking.

Frequently Asked Questions About Afinitor (Everolimus)

What is the main purpose of Afinitor (Everolimus)?

Afinitor (everolimus) primarily serves as an mTOR inhibitor, a type of targeted therapy. Its main purpose is to slow down the growth and spread of cancer cells in various malignancies, including advanced renal cell carcinoma, pancreatic neuroendocrine tumors, and certain types of breast cancer. It also treats non-cancerous tumors associated with Tuberous Sclerosis Complex, such as subependymal giant cell astrocytoma and renal angiomyolipoma, by reducing their size and preventing further growth. This action helps to improve patient outcomes and manage disease progression.

How long do side effects of Everolimus last?

The duration of Everolimus side effects can vary greatly among individuals. Many common side effects, such as mouth sores, fatigue, and rash, may appear early in treatment and can persist throughout the therapy. Some side effects might lessen over time as the body adjusts, while others may require ongoing management or dose adjustments. Serious side effects like pneumonitis or infections can be long-lasting or require immediate medical intervention. It is crucial to report any persistent or worsening side effects to your healthcare provider for proper evaluation and management.

Can Afinitor (Everolimus) be taken with other medications?

Afinitor (everolimus) can interact with numerous other medications, which can significantly affect its efficacy or increase the risk of side effects. Of particular concern are strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, grapefruit juice) which can increase everolimus levels, and strong CYP3A4 inducers (e.g., rifampin, phenytoin, St. John’s wort) which can decrease them. Concomitant use with ACE inhibitors may also increase the risk of angioedema. Always provide a complete list of all prescription drugs, over-the-counter medications, herbal supplements, and vitamins to your doctor and pharmacist to avoid potential interactions.